• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺刺激和阻断自身抗体与 TSH 受体相互作用的异同。

Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.

机构信息

FIRS Laboratories, RSR Ltd, Parc Ty Glas, Llanishen, Cardiff CF14 5DU, UK.

出版信息

J Mol Endocrinol. 2012 Aug 30;49(2):137-51. doi: 10.1530/JME-12-0040. Print 2012 Oct.

DOI:10.1530/JME-12-0040
PMID:22829655
Abstract

Binding of a new thyroid-stimulating human monoclonal autoantibody (MAb) K1-18 to the TSH receptor (TSHR) leucine-rich domain (LRD) was predicted using charge-charge interaction mapping based on unique complementarities between the TSHR in interactions with the thyroid-stimulating human MAb M22 or the thyroid-blocking human MAb K1-70. The interactions of K1-18 with the TSHR LRD were compared with the interactions in the crystal structures of the M22-TSHR LRD and K1-70-TSHR LRD complexes. Furthermore, the predicted position of K1-18 on the TSHR was validated by the effects of TSHR mutations on the stimulating activity of K1-18. A similar approach was adopted for predicting binding of a mouse thyroid-blocking MAb RSR-B2 to the TSHR. K1-18 is predicted to bind to the TSHR LRD in a similar way as TSH and M22. The binding analysis suggests that K1-18 light chain (LC) mimics binding of the TSH-α chain and the heavy chain (HC) mimics binding of the TSH-β chain. By contrast, M22 HC mimics the interactions of TSH-α while M22 LC mimics TSH-β in interactions with the TSHR. The observed interactions in the M22-TSHR LRD and K1-70-TSHR LRD complexes (crystal structures) with TSH-TSHR LRD (comparative model) and K1-18-TSHR LRD (predictive binding) suggest that K1-18 and M22 interactions with the receptor may reflect interaction of thyroid-stimulating autoantibodies in general. Furthermore, K1-70 and RSR-B2 interactions with the TSHR LRD may reflect binding of TSHR-blocking autoantibodies in general. Interactions involving the C-terminal part of the TSHR LRD may be important for receptor activation by autoantibodies.

摘要

新的促甲状腺素人源单克隆自身抗体 (MAb) K1-18 与促甲状腺素受体 (TSHR) 亮氨酸丰富结构域 (LRD) 的结合通过基于 TSHR 与促甲状腺素人源 MAb M22 或甲状腺阻断人源 MAb K1-70 相互作用之间独特互补性的电荷-电荷相互作用映射进行预测。将 K1-18 与 TSHR LRD 的相互作用与 M22-TSHR LRD 和 K1-70-TSHR LRD 复合物的晶体结构中的相互作用进行比较。此外,通过 TSHR 突变对 K1-18 刺激活性的影响验证了 K1-18 在 TSHR 上的预测位置。采用类似的方法预测了鼠甲状腺阻断 MAb RSR-B2 与 TSHR 的结合。预测 K1-18 以与 TSH 和 M22 相似的方式结合到 TSHR LRD。结合分析表明,K1-18 轻链 (LC) 模拟 TSH-α 链的结合,而重链 (HC) 模拟 TSH-β 链的结合。相比之下,M22 HC 模拟 TSH-α与 TSHR 的相互作用,而 M22 LC 模拟 TSH-β与 TSHR 的相互作用。在 M22-TSHR LRD 和 K1-70-TSHR LRD 复合物(晶体结构)中观察到的与 TSH-TSHR LRD(比较模型)和 K1-18-TSHR LRD(预测结合)的相互作用表明,K1-18 和 M22 与受体的相互作用可能反映了一般的促甲状腺素自身抗体的相互作用。此外,K1-70 和 RSR-B2 与 TSHR LRD 的相互作用可能反映了一般的 TSHR 阻断自身抗体的结合。涉及 TSHR LRD C 端部分的相互作用对于自身抗体激活受体可能很重要。

相似文献

1
Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.甲状腺刺激和阻断自身抗体与 TSH 受体相互作用的异同。
J Mol Endocrinol. 2012 Aug 30;49(2):137-51. doi: 10.1530/JME-12-0040. Print 2012 Oct.
2
TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.具有激动剂、拮抗剂和反向激动剂活性的促甲状腺激素受体单克隆抗体。
Methods Enzymol. 2010;485:393-420. doi: 10.1016/B978-0-12-381296-4.00022-1.
3
Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.促甲状腺素自身抗体M22模拟促甲状腺激素与促甲状腺激素受体富含亮氨酸结构域的结合:蛋白质-蛋白质相互作用的比较结构研究
J Mol Endocrinol. 2009 May;42(5):381-95. doi: 10.1677/JME-08-0152. Epub 2009 Feb 16.
4
Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.TSHR 与阻断型 TSHR 自身抗体结合的晶体结构。
J Mol Endocrinol. 2011 Feb 15;46(2):81-99. doi: 10.1530/JME-10-0127. Print 2011 Apr.
5
Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.促甲状腺激素受体突变对单克隆抗体和促甲状腺激素结合及生物活性的影响。
Thyroid. 2006 Dec;16(12):1195-206. doi: 10.1089/thy.2006.16.1195.
6
Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.基于突变和对受体晶体结构此区域模糊性的重新评估,深入了解甲状腺刺激自身抗体与促甲状腺素受体 N 端的相互作用。
Thyroid. 2011 Sep;21(9):1013-20. doi: 10.1089/thy.2011.0147. Epub 2011 Aug 11.
7
Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.一种针对促甲状腺激素受体的人源单克隆自身抗体的特性:序列结构与功能
Thyroid. 2004 Aug;14(8):560-70. doi: 10.1089/1050725041692918.
8
A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.一种具有促甲状腺素阻断活性的人促甲状腺素受体单克隆自身抗体。
Thyroid. 2008 Jul;18(7):735-46. doi: 10.1089/thy.2007.0327.
9
FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.促卵泡激素(FSH)和促甲状腺激素(TSH)与其各自受体的结合:相似性、差异及对糖蛋白激素特异性的影响
J Mol Endocrinol. 2008 Sep;41(3):145-64. doi: 10.1677/JME-08-0040. Epub 2008 Jul 7.
10
Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.一种针对促甲状腺激素受体的单克隆抗体的特性,该抗体可作为一种强效的甲状腺刺激自身抗体拮抗剂。
Thyroid. 2005 Jul;15(7):672-82. doi: 10.1089/thy.2005.15.672.

引用本文的文献

1
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.别构调节 G 蛋白偶联受体:从分子机制多样性到多个别构结合位点及其配体。
Int J Mol Sci. 2023 Mar 24;24(7):6187. doi: 10.3390/ijms24076187.
2
Structure of full-length TSH receptor in complex with antibody K1-70™.全长 TSH 受体与抗体 K1-70™复合物的结构。
J Mol Endocrinol. 2022 Dec 7;70(1). doi: 10.1530/JME-22-0120. Print 2023 Jan 1.
3
Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.
论证胰岛素样生长因子受体-I参与甲状腺相关眼病
Front Endocrinol (Lausanne). 2017 Jan 3;7:167. doi: 10.3389/fendo.2016.00167. eCollection 2016.
4
Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor-LH/CG Receptor Chimeras: The Contribution of Leonard D. Kohn.促甲状腺激素受体自身抗体的生物测定,从FRTL-5细胞到促甲状腺激素受体-黄体生成素/绒毛膜促性腺激素受体嵌合体:伦纳德·D·科恩的贡献
Front Endocrinol (Lausanne). 2016 Jul 25;7:103. doi: 10.3389/fendo.2016.00103. eCollection 2016.
5
Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor's Extracellular Hinge Region.促黄体生成素(LH)和人绒毛膜促性腺激素(hCG)信号激活的差异由LH/CG受体的细胞外铰链区介导。
Front Endocrinol (Lausanne). 2015 Sep 22;6:140. doi: 10.3389/fendo.2015.00140. eCollection 2015.
6
TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.表达促甲状腺激素受体的纤维细胞与甲状腺相关眼病
Nat Rev Endocrinol. 2015 Mar;11(3):171-81. doi: 10.1038/nrendo.2014.226. Epub 2015 Jan 6.
7
Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.替普罗单抗,一种胰岛素样生长因子-1受体(IGF-1R)阻断单克隆抗体,可抑制成纤维细胞中的促甲状腺激素(TSH)和IGF-1作用。
J Clin Endocrinol Metab. 2014 Sep;99(9):E1635-40. doi: 10.1210/jc.2014-1580. Epub 2014 May 30.
8
Novel insights on thyroid-stimulating hormone receptor signal transduction.促甲状腺激素受体信号转导的新见解。
Endocr Rev. 2013 Oct;34(5):691-724. doi: 10.1210/er.2012-1072. Epub 2013 May 3.